Cardiac angiogenesis and gene therapy

A strategy for myocardial revascularization

Adam H. Hamawy, Leonard Y. Lee, Ronald Crystal, Todd K. Rosengart

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Angiogenesis, the de novo formation of new vasculature, is a critical response to ischemia that provides neovascularization of ischemic tissues. In therapeutic angiogenesis, an angiogen-a mediator that induces angiogenesis-is delivered to targeted tissues, augmenting the native angiogenic process and enhancing reperfusion of ischemic tissues. Gene transfer is a novel means of providing therapeutic angiogenesis: the cDNA coding for specific angiogens, rather than the proteins themselves, is administered to the tissues in which angiogenesis is desired. This review is focused on therapeutic angiogenesis based on gene transfer strategies for the provision of myocardial revascularization. Cun-Opin Cardiol 1999, 14:515-522.

Original languageEnglish
Pages (from-to)515-522
Number of pages8
JournalCurrent Opinion in Cardiology
Volume14
Issue number6
DOIs
Publication statusPublished - 1 Dec 1999
Externally publishedYes

Fingerprint

Myocardial Revascularization
Genetic Therapy
Genes
Reperfusion
Therapeutics
Ischemia
Complementary DNA
Proteins
succinic acid drug combination aspirin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac angiogenesis and gene therapy : A strategy for myocardial revascularization. / Hamawy, Adam H.; Lee, Leonard Y.; Crystal, Ronald; Rosengart, Todd K.

In: Current Opinion in Cardiology, Vol. 14, No. 6, 01.12.1999, p. 515-522.

Research output: Contribution to journalArticle

Hamawy, Adam H. ; Lee, Leonard Y. ; Crystal, Ronald ; Rosengart, Todd K. / Cardiac angiogenesis and gene therapy : A strategy for myocardial revascularization. In: Current Opinion in Cardiology. 1999 ; Vol. 14, No. 6. pp. 515-522.
@article{12df6c7d71314cdabf5efe7dc951bb51,
title = "Cardiac angiogenesis and gene therapy: A strategy for myocardial revascularization",
abstract = "Angiogenesis, the de novo formation of new vasculature, is a critical response to ischemia that provides neovascularization of ischemic tissues. In therapeutic angiogenesis, an angiogen-a mediator that induces angiogenesis-is delivered to targeted tissues, augmenting the native angiogenic process and enhancing reperfusion of ischemic tissues. Gene transfer is a novel means of providing therapeutic angiogenesis: the cDNA coding for specific angiogens, rather than the proteins themselves, is administered to the tissues in which angiogenesis is desired. This review is focused on therapeutic angiogenesis based on gene transfer strategies for the provision of myocardial revascularization. Cun-Opin Cardiol 1999, 14:515-522.",
author = "Hamawy, {Adam H.} and Lee, {Leonard Y.} and Ronald Crystal and Rosengart, {Todd K.}",
year = "1999",
month = "12",
day = "1",
doi = "10.1097/00001573-199911000-00012",
language = "English",
volume = "14",
pages = "515--522",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Cardiac angiogenesis and gene therapy

T2 - A strategy for myocardial revascularization

AU - Hamawy, Adam H.

AU - Lee, Leonard Y.

AU - Crystal, Ronald

AU - Rosengart, Todd K.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Angiogenesis, the de novo formation of new vasculature, is a critical response to ischemia that provides neovascularization of ischemic tissues. In therapeutic angiogenesis, an angiogen-a mediator that induces angiogenesis-is delivered to targeted tissues, augmenting the native angiogenic process and enhancing reperfusion of ischemic tissues. Gene transfer is a novel means of providing therapeutic angiogenesis: the cDNA coding for specific angiogens, rather than the proteins themselves, is administered to the tissues in which angiogenesis is desired. This review is focused on therapeutic angiogenesis based on gene transfer strategies for the provision of myocardial revascularization. Cun-Opin Cardiol 1999, 14:515-522.

AB - Angiogenesis, the de novo formation of new vasculature, is a critical response to ischemia that provides neovascularization of ischemic tissues. In therapeutic angiogenesis, an angiogen-a mediator that induces angiogenesis-is delivered to targeted tissues, augmenting the native angiogenic process and enhancing reperfusion of ischemic tissues. Gene transfer is a novel means of providing therapeutic angiogenesis: the cDNA coding for specific angiogens, rather than the proteins themselves, is administered to the tissues in which angiogenesis is desired. This review is focused on therapeutic angiogenesis based on gene transfer strategies for the provision of myocardial revascularization. Cun-Opin Cardiol 1999, 14:515-522.

UR - http://www.scopus.com/inward/record.url?scp=0033220524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033220524&partnerID=8YFLogxK

U2 - 10.1097/00001573-199911000-00012

DO - 10.1097/00001573-199911000-00012

M3 - Article

VL - 14

SP - 515

EP - 522

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 6

ER -